Cite
HARVARD Citation
Xu, X. et al. (2017). Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma. Clinical pharmacology & therapeutics. 101 (6), pp. 721-724. [Online].